Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Agnosia × Sevoflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Agnosia 1

Interventions

Sodium Chloride 2 Ropivacaine 2 Propofol 2 Ketamine 2 Analgesics, Opioid 2 Analgesia, Patient-Controlled 2 parecoxib 1 Tea 1 Tapentadol 1 Surveys and Questionnaires 1 Sevoflurane 1 Lidocaine 1 Ketorolac 1 Epinephrine 1 Dexamethasone 1 Clonidine 1 Celecoxib 1 Anesthesia, General 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡